X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare J.B.Chemicals with VENUS REMEDIES - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs VENUS REMEDIES - Comparison Results

J.B.CHEMICALS    Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS VENUS REMEDIES J.B.CHEMICALS/
VENUS REMEDIES
 
P/E (TTM) x 15.0 -693.1 - View Chart
P/BV x 2.4 0.2 1,168.0% View Chart
Dividend Yield % 0.2 0.0 -  

Financials

 J.B.CHEMICALS   VENUS REMEDIES
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-16
VENUS REMEDIES
Mar-16
J.B.CHEMICALS/
VENUS REMEDIES
5-Yr Chart
Click to enlarge
High Rs318218 145.9%   
Low Rs20082 243.0%   
Sales per share (Unadj.) Rs148.0365.6 40.5%  
Earnings per share (Unadj.) Rs19.11.5 1,284.2%  
Cash flow per share (Unadj.) Rs23.937.9 63.1%  
Dividends per share (Unadj.) Rs0.500-  
Dividend yield (eoy) %0.20-  
Book value per share (Unadj.) Rs128.9382.5 33.7%  
Shares outstanding (eoy) m84.8211.44 741.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.70.4 426.2%   
Avg P/E ratio x13.6101.0 13.4%  
P/CF ratio (eoy) x10.84.0 273.1%  
Price / Book Value ratio x2.00.4 511.7%  
Dividend payout %2.60-   
Avg Mkt Cap Rs m21,9511,717 1,278.8%   
No. of employees `0002.71.0 268.0%   
Total wages/salary Rs m1,841324 567.6%   
Avg. sales/employee Rs Th4,590.94,100.7 112.0%   
Avg. wages/employee Rs Th673.4318.0 211.7%   
Avg. net profit/employee Rs Th592.116.7 3,552.4%   
INCOME DATA
Net Sales Rs m12,5514,183 300.1%  
Other income Rs m54220 2,694.5%   
Total revenues Rs m13,0934,203 311.5%   
Gross profit Rs m2,055812 253.2%  
Depreciation Rs m412417 98.9%   
Interest Rs m96380 25.2%   
Profit before tax Rs m2,08835 5,949.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m46918 2,591.7%   
Profit after tax Rs m1,61917 9,521.8%  
Gross profit margin %16.419.4 84.4%  
Effective tax rate %22.551.6 43.6%   
Net profit margin %12.90.4 3,173.1%  
BALANCE SHEET DATA
Current assets Rs m7,7782,771 280.7%   
Current liabilities Rs m4,3581,931 225.6%   
Net working cap to sales %27.220.1 135.8%  
Current ratio x1.81.4 124.4%  
Inventory Days Days55125 43.7%  
Debtors Days Days8054 148.9%  
Net fixed assets Rs m5,7135,328 107.2%   
Share capital Rs m170114 148.3%   
"Free" reserves Rs m10,5474,177 252.5%   
Net worth Rs m10,9374,376 249.9%   
Long term debt Rs m01,911 0.0%   
Total assets Rs m15,5748,428 184.8%  
Interest coverage x22.81.1 2,089.0%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.80.5 162.4%   
Return on assets %11.04.7 233.8%  
Return on equity %14.80.4 3,809.9%  
Return on capital %20.06.6 302.5%  
Exports to sales %48.70-   
Imports to sales %7.120.5 34.5%   
Exports (fob) Rs m6,115NA-   
Imports (cif) Rs m889858 103.5%   
Fx inflow Rs m6,1690-   
Fx outflow Rs m1,285858 149.7%   
Net fx Rs m4,884-858 -569.0%   
CASH FLOW
From Operations Rs m1,397469 297.9%  
From Investments Rs m-32029 -1,096.9%  
From Financial Activity Rs m-1,196-464 258.0%  
Net Cashflow Rs m-10235 -296.5%  

Share Holding

Indian Promoters % 55.4 32.9 168.6%  
Foreign collaborators % 0.3 0.0 -  
Indian inst/Mut Fund % 3.4 0.2 1,883.3%  
FIIs % 3.9 0.6 672.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 66.4 55.7%  
Shareholders   30,437 20,121 151.3%  
Pledged promoter(s) holding % 0.0 36.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   SUVEN LIFE  SHASUN PHARMA  PFIZER  GLENMARK PHARMA  ORCHID PHARMA LTD  

Compare J.B.CHEMICALS With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Global Stock Markets Chart Modest Gains(RoundUp)

Global financial markets ended the holiday shortened week with modest gains. The rally put behind days of decline as concerns regarding swift interest rates hikes were put to ease.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

The Foundation for Sensex 100,000 is Laid(The 5 Minute Wrapup)

Feb 17, 2018

Top three reasons for Tanushree's presentation at Equitymaster Conference to be centered around a possible 30% correction.

India's Rs 1,66,276 Crore Problem(Vivek Kaul's Diary)

Feb 15, 2018

That's the loss, the government owned public sector enterprises are expected to make this year.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

How I Beat the Index by 2x... And Why I Believe This Could Happen Again(Smart Contrarian)

Feb 12, 2018

Will Microcap Millionaires be able to replicate its past performance of beating the index by 2x?

NPAs Set to Rise Further with New RBI Rules(Chart Of The Day)

Feb 15, 2018

The RBI overhauls bad loan framework. Banks may come under additional pressure due to rising NPAs and increased provisioning.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Feb 23, 2018 (Close)

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS 8-QTR ANALYSIS

COMPARE J.B.CHEMICALS WITH

MARKET STATS